PharmaZorg
Healx
AI platform that searches existing and new drug candidates for rare diseases with few available treatments.
About
Healx combines biomedical literature, disease biology, and drug data to rank potential treatments and combinations for rare diseases. This can make laboratory research more targeted. In July 2026, the first patient received HLX-4310 in a phase 1/2 study on sarcomas. This is an important step, but not yet proof that the treatment works.
AI factor
AI can search for connections between diseases, targets, and compounds across many data sources simultaneously. Researchers choose which hypotheses enter the laboratory and eventually a clinical study.
Sources
Inspiration sourced from AI For Good. Not an Arnaldus customer case.